-
Oct 24, 2024 | 
inchcape.com | Mark McCarthy
Continued growth, with further contract wins, and FY 2024 outlook reiterated Revenue growth supported by recent Distribution contract wins and acquisitions: Group revenue of £2.2bn, up 2% at constant currency, with organic revenue down (1)%: Key markets stabilising in the Americas Mixed market momentum in APAC Robust performance in Europe, reflecting order bank unwind and some growth in order take Strategic progress and execution on capital allocation policy: Nine Distribution contract wins...
-
Sep 9, 2024 | .html&sz=64)
fis.tu-dresden.de | Daniel Graeber |Mark McCarthy |Tom Shatwell |Dietrich Borchardt
Abstract External IDs PubMed 38280872
-
Aug 5, 2024 | 
inchcape.com | Mark McCarthy
This exciting partnership with FOTON enables Inchcape to diversify its local distribution portfolio by entering entirely new segments of the Australian market, including utes and light-duty trucks, and further strengthens our presence in the light commercial vehicle segment with FOTON’s vans also forming part of the local product pipeline.
-
May 30, 2024 | 
inchcape.com | Mark McCarthy
Case Study | May 30, 2024 Mobilising Hearts - an alliance between Inchcape Colombia and the FundaFe Foundation - is a transformative programme dedicated to enhancing the lives of children with disabilities. With the collaboration of our colleagues and by ingeniously repurposing discarded spare parts, the initiative crafts orthopaedic prostheses, thereby offering newfound mobility and hope to those in need.
-
May 24, 2024 | 
inchcape.com | Mark McCarthy
Inchcape plc, the leading global automotive distributor, this held the latest in its series of ‘In the driving seat‘ webinars. This edition of ‘In the driving seat’, focusing on ‘Our Distribution Model’, took viewers through Inchcape’s commercial and financial dynamics, its technology, its partnerships with OEM partners (Original Equipment Manufacturers) and the benefits Inchcape brings through value-added services, including Finance & Insurance and Parts.
-
Mar 6, 2024 | 
nature.com | Minna K. Karjalainen |Eeva Sliz |Elias Allara |Weihua Zhang |Pekka Jousilahti |Kati Kristiansson | +46 more
AbstractGenome-wide association analyses using high-throughput metabolomics platforms have led to novel insights into the biology of human metabolism1,2,3,4,5,6,7. This detailed knowledge of the genetic determinants of systemic metabolism has been pivotal for uncovering how genetic pathways influence biological mechanisms and complex diseases8,9,10,11.
-
Feb 21, 2024 | 
inchcape.com | Mark McCarthy
2023 was a standout year for Inchcape with a record 18 new OEM deals signed. In 2023 more brands – like Subaru, Mercedes, Tata, as well as Chinese OEMs like Great Wall, Changan and BYD – chose Inchcape as their distribution partner across Europe, Africa, the Americas and APAC. By the end of 2023, we had 59 distribution partnerships in place with OEM brand partners.
-
Feb 19, 2024 | 
nature.com | Konstantinos Hatzikotoulas |Henry Taylor |Xianyong Yin |Kim Lorenz |Mark McCarthy |Anubha Mahajan | +6 more
AbstractType 2 diabetes (T2D) is a heterogeneous disease that develops through diverse pathophysiological processes1,2 and molecular mechanisms that are often specific to cell type3,4. Here, to characterize the genetic contribution to these processes across ancestry groups, we aggregate genome-wide association study data from 2,535,601 individuals (39.7% not of European ancestry), including 428,452 cases of T2D.
-
Dec 2, 2023 | 
inchcape.com | BYD Singapore |Mark McCarthy
Inchcape, the leading global automotive distributor, has agreed a distribution partnership between Inchcape and BYD Singapore. Under the terms of this partnership, Inchcape will now be the distributor for BYD commercial vehicles in Singapore including the company’s T9R model. This distribution agreement, exclusive to Singapore, marks the commencement of a partnership with BYD Singapore and strengthens Inchcape’s commitment to providing high-quality commercial vehicles.
-
Nov 2, 2023 | 
nature.com | Charles C. Wykoff |Ehsan Ullah |Emily Y. Chew |Wadih M. Zein |Mark McCarthy |Jeffrey Hofmann | +1 more
AbstractAge-related macular degeneration (AMD), a complex neurodegenerative disease, is a leading cause of visual impairment worldwide with a strong genetic component. Genetic studies have identified several loci, but few causal genes with functional characterization. Here we highlight multiple lines of evidence which show a causal role in AMD for SLC16A8, which encodes MCT3, a retinal pigment epithelium (RPE) specific lactate transporter.
